The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-(1-(3-Methoxyphenyl)ethyl)-4-(2-(3-methoxypropylamino)pyridin-4-yl)benzamide ID: ALA4588929
Chembl Id: CHEMBL4588929
PubChem CID: 155567304
Max Phase: Preclinical
Molecular Formula: C24H27N3O3
Molecular Weight: 405.50
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc([C@@H](C)NC(=O)c2ccc(-c3ccnc(NCCCO)c3)cc2)c1
Standard InChI: InChI=1S/C24H27N3O3/c1-17(20-5-3-6-22(15-20)30-2)27-24(29)19-9-7-18(8-10-19)21-11-13-26-23(16-21)25-12-4-14-28/h3,5-11,13,15-17,28H,4,12,14H2,1-2H3,(H,25,26)(H,27,29)/t17-/m1/s1
Standard InChI Key: JITJVUCWRMTDAV-QGZVFWFLSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 405.50Molecular Weight (Monoisotopic): 405.2052AlogP: 4.04#Rotatable Bonds: 9Polar Surface Area: 83.48Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.47CX LogP: 2.90CX LogD: 2.85Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.47Np Likeness Score: -0.86
References 1. Hobson AD, Judge RA, Aguirre AL, Brown BS, Cui Y, Ding P, Dominguez E, DiGiammarino E, Egan DA, Freiberg GM, Gopalakrishnan SM, Harris CM, Honore MP, Kage KL, Kapecki NJ, Ling C, Ma J, Mack H, Mamo M, Maurus S, McRae B, Moore NS, Mueller BK, Mueller R, Namovic MT, Patel K, Pratt SD, Putman CB, Queeney KL, Sarris KK, Schaffter LM, Stoll V, Vasudevan A, Wang L, Wang L, Wirthl W, Yach K.. (2018) Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using Structure-Based Drug Design., 61 (24): [PMID:30384606 ] [10.1021/acs.jmedchem.8b01098 ]